ID SYI_TROWT Reviewed; 1056 AA. AC Q83G52; DT 20-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 20-DEC-2005, sequence version 2. DT 27-MAR-2024, entry version 120. DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003}; DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003}; DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003}; DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003}; GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; GN OrderedLocusNames=TWT_477; OS Tropheryma whipplei (strain Twist) (Whipple's bacillus). OC Bacteria; Actinomycetota; Actinomycetes; Micrococcales; Tropherymataceae; OC Tropheryma. OX NCBI_TaxID=203267; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Twist; RX PubMed=12902375; DOI=10.1101/gr.1474603; RA Raoult D., Ogata H., Audic S., Robert C., Suhre K., Drancourt M., RA Claverie J.-M.; RT "Tropheryma whipplei twist: a human pathogenic Actinobacteria with a RT reduced genome."; RL Genome Res. 13:1800-1809(2003). CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS CC can inadvertently accommodate and process structurally similar amino CC acids such as valine, to avoid such errors it has two additional CC distinct tRNA(Ile)-dependent editing activities. One activity is CC designated as 'pretransfer' editing and involves the hydrolysis of CC activated Val-AMP. The other activity is designated 'posttransfer' CC editing and involves deacylation of mischarged Val-tRNA(Ile). CC {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L- CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666, CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528, CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and CC one for editing. The misactivated valine is translocated from the CC active site to the editing site, which sterically excludes the CC correctly activated isoleucine. The single editing site contains two CC valyl binding pockets, one specific for each substrate (Val-AMP or Val- CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SEQUENCE CAUTION: CC Sequence=AAO44574.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AE014184; AAO44574.1; ALT_INIT; Genomic_DNA. DR RefSeq; WP_011096241.1; NC_004572.3. DR AlphaFoldDB; Q83G52; -. DR SMR; Q83G52; -. DR STRING; 203267.TWT_477; -. DR GeneID; 67388063; -. DR KEGG; twh:TWT_477; -. DR eggNOG; COG0060; Bacteria. DR HOGENOM; CLU_001493_1_1_11; -. DR OrthoDB; 9810365at2; -. DR Proteomes; UP000002200; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0000049; F:tRNA binding; IEA:InterPro. DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033709; Anticodon_Ile_ABEc. DR InterPro; IPR002301; Ile-tRNA-ligase. DR InterPro; IPR023586; Ile-tRNA-ligase_type2. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR NCBIfam; TIGR00392; ileS; 1. DR PANTHER; PTHR42780:SF1; ISOLEUCINE--TRNA LIGASE, CYTOPLASMIC; 1. DR PANTHER; PTHR42780; SOLEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF19302; DUF5915; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR PRINTS; PR00984; TRNASYNTHILE. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 2. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding; KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc. FT CHAIN 1..1056 FT /note="Isoleucine--tRNA ligase" FT /id="PRO_0000098571" FT REGION 1..26 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 63..73 FT /note="'HIGH' region" FT MOTIF 632..636 FT /note="'KMSKS' region" FT COMPBIAS 1..19 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 635 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003" SQ SEQUENCE 1056 AA; 119751 MW; D1D531A27E790967 CRC64; MCDQGEVSSQ NSSDYKEQRP TPRPNLPKIE ESVLAFWSSD KTFEASLEQR QHGKRWVFYD GPPFANGLPH FGHLLTGYIK DAIPRYQTMR GQYVPRVFGW DTHGLPAELE AMKRLGITEK SQIESMGIAS FNEAARKSVL TYVDQWEEYV NRQARWVDFK NGYKTLDLDY MESVLWAFKT LYKKGVIYEG YKVLPYCWND QTPLSNHELR MDDEVYKQRL DDSLTVTFPL IGQKAKTCGL DGVAALAWTT TPWTLPSNMA LIVSPNVEYV VVSSARQNSN SDFLLCKSSL DSYAECLGYE SGQDARASIR RTLLGKEIEG IHYKPLFDYY ADLHNAFTIL SDNYVDVTEG TGIVHASPAH GEDDKRVCDA FGVPTVVSIN DAACFTDVIS NYAGMHIFDA NAVIRSDLSR DGRILRHESY KHSYPHCWRC RSPLIYKAVT SWFFRITDSV NRMLELNQQI NWVPKSVKNG QFAKWLSSAK DWSISRTRYW GTPIPVWKSD NPEYPRIDCY GSLKELEDDF GIKLTDLHRP EIDRLTRPNP DDPTGASTMR RVPDVLDVWF DAASMPFAQL HYPFENIERF EANKSADFIV EYAGQIRGWF YLLHAMSTAL FDGVAFKNAI CHGIVLGDDG QKASKSLRNY PDVYDVFENE GSDAVRWYLI SSSILRGGSL IVSRKKIQDA IRQYITPLWS SWYFFHIYSE AARPGGYKAR FSVDSQDILD RYILSKTGLL VEDVTRFMDS FDMASAALQL RDFVAVLTNW YIRRSRDRFW DGSDTGAFDT LYTVLETLCR LGAVFVPMVS EHVYKCLTNS RSVHLSDWPD VATFPNETGL VETMDRVRKI CSTGLSLRKR LGIKARQPLS SAHIRVAQVG SLAQYKDIIS GELNVKTVSI EEGSCTQRML KILPRVAGPR LAGDVQTVIA AARRGDWTDH DGHVTAGGIP LLENEYQLVA GAQDSKNSQP LPFGGSVTLD TRIDETLRSE GVARDTVRQI QIARKEKDLN ITDRISLEVC VPDEQVKNNL LAFSELICKE TLCDRLDILV KKGIDGITVS LEKFRQ //